Acute psychosis in three patients receiving anti-tumour necrosis factor- therapy
نویسندگان
چکیده
منابع مشابه
Salmonella enterica arthritis in a patient with rheumatoid arthritis receiving anti-tumour necrosis factor therapy.
Anti-tumour necrosis factor (TNF) monoclonal antibodies have become an invaluable treatment against chronic inflammatory diseases such as rheumatoid arthritis (RA). However, due to increased risk of opportunistic infections, patients receiving anti-TNF therapy should be closely monitored for serious infections. Here, we describe a case of acute Salmonella_enteritidis infection of a joint arthro...
متن کاملAnti-Tumour Necrosis Factor-α Therapy in Crohn’s Disease
Crohn’s disease is a chronic, relapsing, inflammatory disease of the gastro-intestinal tract. Manifestations of the disease may be severe, and lead to long-term therapy with a variety of medications and/or surgery. There are two main classifications of the disease, including the relapsing-remitting chronic active variety, and the penetrating or fistulising variety. Tumour necrosis factor-alpha ...
متن کاملAnti-tumour necrosis factor therapy in seronegative spondyloarthritis.
S19–23. 13 Desai SR, Veeraraghavan S, Hansell DM, Nikolakopolou A et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004;232:560–7. 14 Wells AU, Hansell DM, Haslam PL, Rubens MB et al. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fi...
متن کاملEndemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy.
Tumour necrosis factor (TNF)-alpha inhibitors are widely used agents in the treatment of a variety of inflammatory and granulomatous diseases. It has long been appreciated that these agents confer an increased risk of tuberculosis; however, more recently it has been recognized that patients being treated with TNFalpha inhibitors are also at significant risk for infection with the endemic fungi,...
متن کاملMycobacterial diseases developed during anti-tumour necrosis factor-α therapy.
Nontuberculous mycobacterial (NTM) disease and tuberculosis (TB) develop during anti-tumour necrosis factor (TNF)-α therapy. We compared clinical characteristics and outcomes between the two diseases. A total of 1165 patients were screened for TB and treated with TNF-α antagonists from July 2004 to July 2013 for the following conditions: inflammatory bowel disease (n = 422), rheumatoid arthriti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Rheumatology
سال: 2008
ISSN: 1462-0324,1462-0332
DOI: 10.1093/rheumatology/ken212